» Articles » PMID: 22488332

Roles of Glutamine Synthetase Inhibition in Epilepsy

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2012 Apr 11
PMID 22488332
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Glutamine synthetase (GS, E.C. 6.3.1.2) is a ubiquitous and highly compartmentalized enzyme that is critically involved in several metabolic pathways in the brain, including the glutamine-glutamate-GABA cycle and detoxification of ammonia. GS is normally localized to the cytoplasm of most astrocytes, with elevated concentrations of the enzyme being present in perivascular endfeet and in processes close to excitatory synapses. Interestingly, an increasing number of studies have indicated that the expression, distribution, or activity of brain GS is altered in several brain disorders, including Alzheimer's disease, schizophrenia, depression, suicidality, and mesial temporal lobe epilepsy (MTLE). Although the metabolic and functional sequelae of brain GS perturbations are not fully understood, it is likely that a deficiency in brain GS will have a significant biological impact due to the critical metabolic role of the enzyme. Furthermore, it is possible that restoration of GS in astrocytes lacking the enzyme could constitute a novel and highly specific therapy for these disorders. The goals of this review are to summarize key features of mammalian GS under normal conditions, and discuss the consequences of GS deficiency in brain disorders, specifically MTLE.

Citing Articles

Activation of glutamine synthetase (GS) as a new strategy for the treatment of major depressive disorder and other GS-related diseases.

Kang J, Kim H, Baek J, Song M, Park H, Jeong W Acta Pharmacol Sin. 2025; .

PMID: 39775502 DOI: 10.1038/s41401-024-01441-2.


WONOEP appraisal: The role of glial cells in focal malformations associated with early onset epilepsies.

Cases-Cunillera S, Quatraccioni A, Rossini L, Ruffolo G, Ono T, Baulac S Epilepsia. 2024; 65(12):3457-3468.

PMID: 39401070 PMC: 11647439. DOI: 10.1111/epi.18126.


Sodium Houttuyfonate Prevents Seizures and Neuronal Cell Loss by Maintaining Glutamatergic System Stability in Male Rats with Kainic Acid-Induced Seizures.

Chang Y, Chen Y, Wang S Biomedicines. 2024; 12(6).

PMID: 38927519 PMC: 11202147. DOI: 10.3390/biomedicines12061312.


Regulation of the Volume-Regulated Anion Channel Pore-Forming Subunit LRRC8A in the Intrahippocampal Kainic Acid Model of Mesial Temporal Lobe Epilepsy.

Ghouli M, Jonak C, Sah R, Fiacco T, Binder D ASN Neuro. 2023; 15:17590914231184072.

PMID: 37410995 PMC: 10331354. DOI: 10.1177/17590914231184072.


Neurological Phenotypes in Mouse Models of Mitochondrial Disease and Relevance to Human Neuropathology.

Olkhova E, Smith L, Bradshaw C, Gorman G, Erskine D, Ng Y Int J Mol Sci. 2023; 24(11).

PMID: 37298649 PMC: 10254022. DOI: 10.3390/ijms24119698.


References
1.
van der Hel W, Notenboom R, Bos I, van Rijen P, van Veelen C, De Graan P . Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy. Neurology. 2005; 64(2):326-33. DOI: 10.1212/01.WNL.0000149636.44660.99. View

2.
FRY B . Glutamine synthesis by Micrococcus pyogenes var. aureus. Biochem J. 1955; 59(4):579-89. PMC: 1215621. DOI: 10.1042/bj0590579. View

3.
Wang Y, Kudoh J, Kubota R, Asakawa S, Minoshima S, Shimizu N . Chromosomal mapping of a family of human glutamine synthetase genes: functional gene (GLUL) on 1q25, pseudogene (GLULP) on 9p13, and three related genes (GLULL1, GLULL2, GLULL3) on 5q33, 11p15, and 11q24. Genomics. 1996; 37(2):195-9. DOI: 10.1006/geno.1996.0542. View

4.
Haberle J, Gorg B, Toutain A, Rutsch F, Benoist J, Gelot A . Inborn error of amino acid synthesis: human glutamine synthetase deficiency. J Inherit Metab Dis. 2006; 29(2-3):352-8. DOI: 10.1007/s10545-006-0256-5. View

5.
Kvamme E, Torgner I, Roberg B . Kinetics and localization of brain phosphate activated glutaminase. J Neurosci Res. 2001; 66(5):951-8. DOI: 10.1002/jnr.10041. View